Today: 9 June 2026
GE Vernova stock price: GEV ends week higher as wind risks shadow next session
31 January 2026
2 mins read

GE Vernova stock price: GEV ends week higher as wind risks shadow next session

New York, January 31, 2026, 16:27 EST — Markets have closed.

  • Shares ended the session 1.3% higher at $726.37, having surged to an intraday peak of $752.
  • Investors are balancing a more optimistic 2026 forecast with ongoing concerns over offshore wind execution risks.
  • U.S. data and earnings reports due next week may set the tone for risk appetite at Monday’s open.

GE Vernova shares closed Friday at $726.37, up 1.3%. The stock climbed roughly 9% on the week, hitting over $750 during intraday trading before pulling back.

The stock’s wild swings have made it a test case for whether investors are ready to pay a premium for firms linked to growing electricity demand — covering everything from data centers to grid upgrades — despite ongoing challenges with financing costs and project delays.

This matters now as the company’s recent guidance reset has drawn fresh momentum money into the stock, even as its wind business continues to generate headlines that can swiftly sway sentiment.

GE Vernova dropped its 2025 annual report and Form 10-K on Friday, with CEO Scott Strazik spotlighting “electric power” as the upcoming investment wave. “The global energy system is undergoing a major transformation,” Strazik noted in his letter. GE Vernova

A filing with the U.S. Securities and Exchange Commission on Jan. 28 revealed the company posted its fourth-quarter and full-year 2025 results on its investor relations website.

In the earnings webcast transcript, the company boosted its 2026 revenue outlook to $44 billion-$45 billion and increased its free cash flow forecast to $5.0 billion-$5.5 billion. It also projected wind EBITDA losses around $400 million in 2026; EBITDA measures profit before interest, taxes, depreciation, and amortization.

GE Vernova posted fourth-quarter orders totaling $22.2 billion, with its backlog of unfilled orders rising to $150 billion. Chief Financial Officer Ken Parks highlighted “robust quarterly orders” alongside “significant free cash flow generation.” GE Vernova

The wind segment remains the key wildcard. GE Vernova warned missing the installation of 11 turbines at the Vineyard Wind project off Massachusetts could slash revenue by a low double-digit percentage, hitting roughly $400 million in losses. Tariffs implemented last year also dragged on performance. On another note, CEO Strazik told analysts the company secured over $2 billion in electrification orders tied to data centers slated for 2025. He added the backlog in power and electrification should strengthen as the Prolec GE acquisition wraps up.

Next week brings a jam-packed earnings schedule alongside fresh U.S. labor figures that could shake up rate forecasts and the wider market. The U.S. Bureau of Labor Statistics will release the January jobs report on Feb. 6—an important gauge for investors tracking the Fed’s rate moves.

The downside remains clear-cut: any further delays in offshore wind projects or a larger-than-anticipated cash burn in the wind division could swiftly derail the “AI-grid” narrative. Investors are keenly focused on whether backlog translates into actual margins and cash, rather than just impressive headlines and order volumes.

Markets reopen Monday. The next key date on the calendar: April 22, when GE Vernova plans to hold its first-quarter 2026 earnings webcast.

Stock Market Today

  • Soybean Prices Decline Amid Lower Export Shipments and Reduced Speculative Positions
    June 9, 2026, 9:21 AM EDT. Soybean prices fell between 2 and 5 ½ cents on Monday, with the national average cash price dropping to $10.58 3/4 per bushel. Export shipments for the week ending June 4 decreased by 21.2% from the previous week, totaling 398,186 MT, and are down 28.8% year-over-year. Key buyers included Egypt, China, and Mexico. Marketing year exports stand 20.3% lower compared to last year. Meanwhile, speculative traders reduced their net long positions in soybean futures and options by 33,502 contracts, signaling cautious market sentiment. Soymeal and soy oil futures also declined modestly. A private export sale of 264,000 MT was reported for the 2026/27 season, but overall market pressure weighs on prices going into the week.

Latest articles

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
Shell share price slips as buyback wraps up; earnings on deck next week
Previous Story

Shell share price slips as buyback wraps up; earnings on deck next week

Renesas stock price: Wolfspeed stake update lands days before Feb. 5 earnings
Next Story

Renesas stock price: Wolfspeed stake update lands days before Feb. 5 earnings

Go toTop